中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共3条，第1-3条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Chen, Zhanhong;  Wang, Xiaojia;  Huang, Jian;  Zheng, Yabing;  Shao, Xiying;  Cao, Wenming;  Chen, Junqing;  Ye, Weiwu;  Ping, Huang;  Li, Guangliang;  Lei, Lei;  Shi, Lei;  Huang, Yuan;  Zou, Weibin;  Wang, Rong;  Shen, Xia-Bo;  Lou, Caijin
收藏  |  浏览/下载：33/0  |  提交时间：2022/12/23
Maintenance endocrine therapy prolonged progression-free survival of first-line chemotherapy with trastuzumab in advanced HR-positive, HER2-positive breast cancer patients. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Shen, Xia-Bo;  Wu, Jia-Yi;  Chen, Ke-Yu;  Fang, Zi-Ru;  Li, Guang-Liang;  Zou, Wei-Bin;  Wang, Xiaojia;  Shao, Xi-Ying
收藏  |  浏览/下载：32/0  |  提交时间：2022/12/23
Everolimus combined with endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: A retrospective study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Shen, Xia-Bo;  Li, Guang-Liang;  Zheng, Ya-Bing;  Chen, Zhan-Hong;  Cao, Wen-Ming;  Shao, Xi-Ying;  Wang, Xiao-Jia
收藏  |  浏览/下载：45/0  |  提交时间：2022/01/10